Showing results (51-60 of 148) with videos related to
Sort By:
Pageof 15
Gynecologic Oncology|January 19, 2016
The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancyAllison A Gockley, Alexander Melamed, Naima T Joseph, et al.Gynecologic Oncology|January 21, 2014
Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovaryMichelle Davis, J Alejandro Rauh-Hain, Carolina Andrade, et al.Plos One|February 16, 2018
Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survivalSarah C Markt, Tianyu Tang, Angel M Cronin, et al.Gynecologic Oncology|August 4, 2016
Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for ageAlexander Melamed, Allison A Gockley, Naima T Joseph, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2015
Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 DecadesSue Yazaki Sun, Alexander Melamed, Naima T Joseph, et al.Gynecologic Oncology|August 14, 2012
A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinomaSusana M Campos, Richard T Penson, Ursula Matulonis, et al.Abdominal Imaging|April 4, 2007
PET-CT vs. CT alone in ovarian cancer recurrenceSunit Sebastian, Susanna I Lee, Neil S Horowitz, et al.Gynecologic Oncology|August 5, 2014
Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinomaMichael J Worley, Michelle Davis, Saba H Berhie, et al.Gynecologic Oncology|May 9, 2006
CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecanGabrielle Gossner, Robert L Coleman, David G Mutch, et al.Current Problems in Cancer|August 18, 2020
Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort studyRichard A Harvey, Kevin M Elias, Adrian Lim, et al.Pageof 15